Business
CSL kicks off US trial for COVID-19 treatment – Sydney Morning Herald
The Australian biotech giant will launch a US study testing whether a treatment candidate helps treat COVID-19 related pneumonia.
CSL executive vice president, head of research and development Bill Mezzanotte said the company was focused on global collaboration when considering its virus projects. “We have gone all in on the ba…
Continue Reading
-
Business20 hours agoTop brokers name 3 ASX shares to buy next week 16 November 2025
-
General8 hours agoZac Lomax released by Eels for ‘opportunities outside NRL’, fuelling speculation of R360 switch
-
Business24 hours agoNvidia’s quiet move into quantum computing could reshape the next frontier of AI
-
Business22 hours ago3 US dividend stocks that can boost an ASX retirement portfolio